Corneal critical barrier against the penetration of dexamethasone and lomefloxacin hydrochloride: Evaluation by the activation energy for drug partition and diffusion in cornea

被引:12
作者
Yasueda, Shin-ichi [1 ]
Higashiyama, Masayo [1 ]
Yamaguchi, Masazumi [1 ]
Isowaki, Akiharu [1 ]
Ohtori, Akira [1 ]
机构
[1] Senju Pharmaceut Co LTD, Chuo Ku, Osaka, Japan
关键词
corneal permeability; in vitro; dexamethasone; lomefloxacin hydrochloride; partition; diffusion; activation energy;
D O I
10.1080/03639040701377995
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The cornea is a solid barrier against drug permeation. We searched the critical barrier of corneal drug permeation using a hydrophobic drug, dexamethasone (DM), and a hydrophilic drug, lomefloxacin hydrochloride (LFLX). The activation energies for permeability of DM and LFLX across the intact cornea were 88.0 and 42.1 kJ/mol, respectively. Their activation energies for permeability across the cornea without epithelium decreased to 33.1 and 16.6 kJ/mol. respectively. The results show that epithelium is the critical barrier on the cornea against the permeation of a hydrophobic drug of DM as well as a hydrophilic drug of LFLX. The activation energy of partition for DM (66.8 kJ/mol) was approximately 3-fold larger than that of diffusion (21.2 kJ/mol). The results indicate that the partition for the hydrophobic drug of DM to the corneal epithelium is the primary barrier. Thermodynamic evaluation of activation energy for the drug permeation parameters is a good approch to investigate the mechanism of drug permeability.
引用
收藏
页码:805 / 811
页数:7
相关论文
共 24 条
[1]  
*ABB JAP CO LTD, 2005, PACK INS BAR
[2]  
BURSTEIN NL, 1984, INVEST OPHTH VIS SCI, V25, P1453
[3]   INFLUENCE OF SOME PRESERVATIVES ON THE CORNEAL PERMEABILITY OF PILOCARPINE AND DEXAMETHASONE, INVITRO [J].
CAMBER, O ;
EDMAN, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 39 (03) :229-234
[4]  
COOPER E R, 1987, Journal of Controlled Release, V6, P23, DOI 10.1016/0168-3659(87)90061-7
[5]   Predicted permeability of the cornea to topical drugs [J].
Edwards, A ;
Prausnitz, MR .
PHARMACEUTICAL RESEARCH, 2001, 18 (11) :1497-1508
[6]   MECHANISMS OF CORNEAL DRUG PENETRATION .1. INVIVO AND INVITRO KINETICS [J].
GRASS, GM ;
ROBINSON, JR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (01) :3-14
[7]   MECHANISMS OF CORNEAL DRUG PENETRATION .3. MODELING OF MOLECULAR-TRANSPORT [J].
GRASS, GM ;
COOPER, ER ;
ROBINSON, JR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (01) :24-26
[8]   Improvement of the ocular bioavailability of timolol by sorbic acid [J].
Higashiyama, M ;
Inada, K ;
Ohtori, A ;
Tojo, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 272 (1-2) :91-98
[9]   CORNEAL PENETRATION BEHAVIOR OF BETA-BLOCKING-AGENTS .2. ASSESSMENT OF BARRIER CONTRIBUTIONS [J].
HUANG, HS ;
SCHOENWALD, RD ;
LACH, JL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (11) :1272-1279
[10]   Characterization of the carrier-mediated transport of levofloxacin, a fluoroquinolone antimicrobial agent, in rabbit cornea [J].
Kawazu, K ;
Midori, Y ;
Shiono, H ;
Ota, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (07) :797-801